WoundReference improves clinical decisions
 Choose the role that best describes you
Noordenbos J, Doré C, Hansbrough JF, et al.
The Journal of burn care & rehabilitation. Date of publication 1999 Jul 1;volume 20(4):275-81.
1. J Burn Care Rehabil. 1999 Jul-Aug;20(4):275-81. Safety and efficacy of TransCyte for the treatment of partial-thickness burns. Noordenbos J(1), Doré C, Hansbrough JF. Author information: (1)Department of Surgery, University of California, San Diego Medical Center 92103, USA. Standard treatment for extensive partial-thickness burns in the United States and in much of the world involves the application of topical antimicrobial agents and repetitive wound débridements and dressing changes. We evaluated a new biologic wound covering, TransCyte (Advanced Tissue Sciences, La Jolla, Calif, formerly marketed as Dermagraft-Transitional Covering), for the treatment of partial-thickness burns. This material is composed of human newborn fibroblasts which are then cultured on the nylon mesh of Biobrane (Dow B. Hickam, Inc, Sugarland, Tex); the thin silicone membrane bonded to the mesh provides a moisture vapor barrier for the wound. A prospective, randomized, comparison study of silver sulfadiazine and TransCyte was performed with the use of paired wound sites on 14 patients. Wounds treated with TransCyte healed more quickly (mean 11.14 days to 90% epithelialization vs 18.14 days, P = .002). A noncomparison evaluation was then done for an additional 18 patients, and it confirmed excellent wound healing and an absence of infections. There were no infections in the 32 wound sites treated with TransCyte. In the first study group, late wound evaluations (3, 6, and 12 months postburn) were performed with use of the Vancouver Scar Scale. The results indicated that wound sites treated with TransCyte healed with less hypertrophic scarring than sites treated with silver sulfadiazine (P < .001 at 3 and 6 months, P = .006 at 12 months). PMID: 10425589 [Indexed for MEDLINE]
Appears in following Topics:
Cellular and/or Tissue Based Products